Actionable insights straight to your inbox

Equities logo

Opportunities for Tenbaggers in the Microcap Biotech Space

Institutional investors are, by and large, unable to own shares in companies with market valuations of less than $100 million, which means most sellside analysts don't write research on very
Technical analysis can be a fickle beast. No matter how good you get at reading charts and spotting patterns, your careful research can go right out the window in a moment if something major